Berkshire Hathaway’s new CEO Greg Abel used his first letter to shareholders to spotlight a smaller set of long-term equity ...
V2X stock earns a "Strong Buy" rating and a $91.70 target. Learn more about VVX's $4.3 billion T-6 contract-driven backlog ...
US biotech Generate Biomedicines (Nasdaq: GENB) raised $400 million in its initial public offering, selling 25 million shares at $16 each, the midpoint of its range. It marks the largest biotech IPO ...
Cognex Corporation (CGNX) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 11:00 AM ESTCompany ParticipantsMatt Moschner ...
Good afternoon, everyone, and thank you for joining us to review Mobile Infrastructure Corporation's fourth quarter and full year 2025 performance. With us today from Mobile Infrastructure Corporation ...